Epidemic group invests $34 million in potential vaccine printer tech
A coalition seeking to get ahead of the next pandemic has agreed a $34 million deal with German biotech CureVac to develop vaccine "printing" technology that aims to rapidly produce shots against multiple diseases.
from Reuters: Health News https://ift.tt/2EBNMJE
from Reuters: Health News https://ift.tt/2EBNMJE
Comments
Post a Comment